The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

British Journal of Cancer

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Sng, J.-H., Chang, J., Feroze, F., Rahman, N., Tan, W., Lim, S., Lehnert, M., Van Der Pool, S., Wong, J.
مؤلفون آخرون:	NATIONAL UNIVERSITY MEDICAL INSTITUTES
التنسيق:	مقال
منشور في:	2014
الموضوعات:	BRCA1 Breast cancer Chinese
الوصول للمادة أونلاين:	http://scholarbank.nus.edu.sg/handle/10635/112815
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة:	National University of Singapore

مواد مشابهة

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives
بواسطة: Sng, J.-H., وآخرون
منشور في: (2014)

IDENTIFICATION AND CHARACTERISATION OF BRCA GENOMIC REARRANGEMENT IN SINGAPORE PATIENTS WITH EARLY ONSET OR FAMILIAL BREAST AND/OR OVARIAN CANCER
بواسطة: LIM YEW KOON
منشور في: (2019)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
بواسطة: Kang, P., وآخرون
منشور في: (2014)

Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
بواسطة: Kang, P.C.E., وآخرون
منشور في: (2014)

BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer
بواسطة: Ali, A.B., وآخرون
منشور في: (2012)

Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer
بواسطة: Iau, P.T.C., وآخرون
منشور في: (2014)

BRCA1 mutations in the family history clinic
بواسطة: IAU TSAU CHOONG, PHILIP
منشور في: (2010)

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
بواسطة: Lim, Y.K., وآخرون
منشور في: (2012)

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
بواسطة: Lim, Y.K., وآخرون
منشور في: (2011)

A role of BRCA1-associated protein BARD1 in oxidative stress response and signaling and proliferation control
بواسطة: Irminger-Finger, I., وآخرون
منشور في: (2016)

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
بواسطة: Marijon, Hélène, وآخرون
منشور في: (2022)

Functional Analysis of Familial Asp67Glu and Thr1051Ser BRCA1 Mutations in Breast/Ovarian Carcinogenesis
بواسطة: Malinee Pongsavee, وآخرون
منشور في: (2012)

Screening of mutation of BRCA1 in Thai breast cancer patients by Single-Stranded Conformation Polymorphism (SSCP)
بواسطة: Pornpen Panomwan
منشور في: (2006)

Hereditary breast cancer: A brief overview
بواسطة: Sng, J.-H.
منشور في: (2014)

Genetic and epigenetic alterations in the BRCAI gene in Singapore breast and/or ovarian cancer: A population-based study
بواسطة: AZHAR BIN ALI
منشور في: (2010)

Genetic changes resulting in breast and ovarian cancers in BRCA 1/2 negative families in Thailand
بواسطة: Malinee Pongsavee
منشور في: (2023)

Telomere-chromosome integrity in breast cancer
بواسطة: ANURADHA POONEPALLI
منشور في: (2010)

Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis
بواسطة: Poon, Kok-Siong, وآخرون
منشور في: (2021)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
بواسطة: Maxwell C.A., وآخرون
منشور في: (2019)

Role of BRCA2 in DNA repair
بواسطة: CHANG JAW-SHIN
منشور في: (2010)

The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: A case report
بواسطة: Damayanti, Z., وآخرون
منشور في: (2011)

The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: A case report
بواسطة: Damayanti, Z., وآخرون
منشور في: (2011)

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
بواسطة: Yuen, Jeanette, وآخرون
منشور في: (2021)

Evaluation of the relative effectiveness of the 2017 updated Manchester scoring system for predicting BRCA1/2 mutations in a Southeast Asian country
بواسطة: Chew, Winston, وآخرون
منشور في: (2019)

Predictive factors for BRCA1 and BRCA2 genetic testing in an asian clinic-based population
بواسطة: Wong E.S.Y., وآخرون
منشور في: (2020)

Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients
بواسطة: Ngoi, N., وآخرون
منشور في: (2014)

Identification of shared neoantigens in BRCA1-related breast cancer
بواسطة: Lucksica Ruangapirom
منشور في: (2021)

Coping Strategies and Emotional Distress of Patients with Early Stage Breast Cancer and Their Spouses
بواسطة: Pannee Buaniam
منشور في: (2011)

BRCA1 c.2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer.
بواسطة: Sng, J.H., وآخرون
منشور في: (2014)

Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need
بواسطة: Hong, Soo Jung, وآخرون
منشور في: (2019)

Illness perceptions of Indonesian women with breast cancer
بواسطة: Wenny Savitri
منشور في: (2010)

Factors affecting quality of life among patients with post-operative breast cancer in Roi-Et province, Thailand
بواسطة: Ekkasit Mamanee
منشور في: (2011)

Factors affecting quality of life among patients with post-operative breast cancer in Roi-Et province, Thailand
بواسطة: Ekkasit Mamanee
منشور في: (2009)

The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells
بواسطة: Moltira Promkan, وآخرون
منشور في: (2014)

Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore : qualitative study
بواسطة: Ng, Ding Yi, وآخرون
منشور في: (2021)

Calcium intake is not related to breast cancer risk among Singapore Chinese women
بواسطة: Li, J., وآخرون
منشور في: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
بواسطة: Lehnert, M., وآخرون
منشور في: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
بواسطة: Lehnert, M., وآخرون
منشور في: (2016)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
بواسطة: Tacconi, E.M.C, وآخرون
منشور في: (2020)

Early-onset breast cancer in a woman with a germline mobile element insertion resulting in BRCA2 disruption : a case report
بواسطة: Deuitch, Natalie, وآخرون
منشور في: (2020)